25 Jul 2023

Vaping products, medicinal cannabis and the wellness industry included in 2023-24 compliance and enforcement priorities

The Therapeutic Goods Administration (TGA) has published its import, advertising and supply compliance priorities for 2023-24, with nicotine vaping products, medicinal cannabis advertising, and the wellness and beauty industries among the focus areas.

24 Jul 2023

Meningococcal cases 24 July 2023

A case of invasive meningococcal disease has been notified in a 55-year-old male from regional South Australia. The case has been admitted to hospital and is in a stable condition.

24 Jul 2023

Former medical practitioner reprimanded and disqualified for professional misconduct involving scheduled medicines

A former Victorian medical practitioner has been reprimanded by a tribunal and disqualified from applying for registration for 12 months for professional misconduct involving scheduled medicines.

24 Jul 2023

Funding boost for rural GP training welcomed

Around 340 doctors will be funded to go on rural placements run through the John Flynn Prevocational Doctor Program.

24 Jul 2023

Rural Australians absent from bowel cancer screening

Bowel cancer screening is failing to reach Australia’s regional communities, according to a new study.

24 Jul 2023

‘As GPs, we can only try to give hope’

The unexpected death of a patient prompts Dr Andrew Leech to reflect on a mental health care system that has stretched beyond capacity.

21 Jul 2023

Trickling antibiotic pipeline leads to superbug warning

The world is facing an inevitable antimicrobial resistance crisis, the co-author of a new report analysing recent research efforts has said.

21 Jul 2023

Call to get ‘ducks in a row’ for MS-2 Step changes

With medical abortion prescribing set to expand significantly next month, there are evolving concerns when it comes to ensuring patient safety.

21 Jul 2023

GlucaGen Hypokit in short supply until October

Another diabetes medication is now facing supply issues, adding to worldwide shortages of semaglutide and dulaglutide.

21 Jul 2023

New CVD guideline and risk calculator expected to help millions

An Australian-specific calculator is a key feature of the toolkit refresh, which targets conditions responsible for one in four deaths each year.